Literature DB >> 22783790

Cavitating pulmonary tuberculosis: a global challenge.

G Bothamley, M Lipman, O M Kon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22783790      PMCID： PMC4953502          DOI： 10.7861/clinmedicine.12-3-299

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN： 1470-2118            Impact factor:   2.659


× No keyword cloud information.
  2 in total

1.  Multidrug-resistant tuberculosis (MDR-TB) treatment in the UK: a study of injectable use and toxicity in practice.

Authors:  Ann Sturdy; Anna Goodman; Ricardo J José; Angela Loyse; Marie O'Donoghue; Onn Min Kon; Martin J Dedicoat; Thomas S Harrison; Laurence John; Marc Lipman; Graham S Cooke
Journal:  J Antimicrob Chemother       Date:  2011-06-03       Impact factor: 5.790

2.  Results at 30 months of a randomised trial of two 8-month regimens for the treatment of tuberculosis.

Authors:  A J Nunn; A Jindani; D A Enarson
Journal:  Int J Tuberc Lung Dis       Date:  2011-06       Impact factor: 2.373
  2 in total
  1 in total

1.  Rifapentine-linezolid-loaded PLGA microspheres for interventional therapy of cavitary pulmonary tuberculosis: preparation and in vitro characterization.

Authors:  Jieyun Huang; Zhi Chen; Ying Li; Li Li; Guangyu Zhang
Journal:  Drug Des Devel Ther       Date:  2017-03-03       Impact factor: 4.162
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.